Back to All Blog Posts
Jan 21, 2020

Welcome to Our New Board Members

At Zymergen, we use biology to create never-before imagined materials. As we continue to scale and build our growing pipeline of next generation products, we’re proud to announce that we’ve appointed Jay Flatley, Chairman of the Board of Illumina, and Sandra E. Peterson, former Group Worldwide Chairman for Johnson & Johnson, to Zymergen’s Board of Directors. Jay will serve as Lead Independent Director.

As we set out to change the world, we are committed to assembling a world-class roster of board members who can help us uphold the highest standards of fairness, accountability, responsibility and transparency. The appointment of Jay and Sandi, along with our existing board members including Steven Chu, former Secretary of Energy and Nobel Laureate, supports these goals and will strengthen our shared stewardship of Zymergen.

Sandi Peterson, Board Member
Jay Flatley, Lead Independent Director
Both are experts in their respective fields, bringing to Zymergen unique problem-solving styles and perspectives to the table. Between them, we add deep healthcare and genomic technology experience, with practical know-how in scaling businesses into high-growth companies. Their addition continues our practice of bringing together experienced people to collaborate and solve world-changing problems, which has been a cornerstone of our growth and success. Being able to add two board members of Sandi and Jay’s caliber is a privilege and validation of our vision and approach.

Welcome Jay and Sandi to the Zymergen family!